In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Optherion (developing ophthalmic drug candidates and diagnostics) raised $37mm in its Series A financing from Quaker BioVentures, Domain Associates, Johnson & Johnson Development Corp., Purdue Pharma, Pappas Ventures, Biogen Idec New Ventures, and GE Healthcare Financing Services. A member from Quaker and Domain joined the company's board.
In Vitro Diagnostics
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?